Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Gui-Lan Liu"'
Publikováno v:
Journal of Hainan Medical University; Mar2023, Vol. 29 Issue 5, p26-30, 5p
Map-Reduce-Join-Locate: a Data Processing Framework for Decreasing the Processing Cost on Large Data
Publikováno v:
International Journal of Hybrid Information Technology. 10:149-160
Publikováno v:
Journal of Hainan Medical University; Apr2020, Vol. 26 Issue 8, p20-24, 5p
Publikováno v:
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 39:574-580
Autor:
Shu-Jun Xu, Gui-Lan Liu
Publikováno v:
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 37:589-593
Publikováno v:
Proceedings of the 2nd Annual International Conference on Social Science and Contemporary Humanity Development.
Publikováno v:
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 17(2)
To study the relationship between loss of sex chromosomes and prognosis in children with acute myeloid leukemia (AML) M2 subtype.According to cytogenetic characteristics, 106 children with AML were divided into three groups: patients with normal kary
Publikováno v:
Chinese Journal of Biotechnology. 22:950-955
The gdrA, gdrB gene coding glycerol dehydratase reactivase factor were amplified by using the genomic DNA of Klebsiella pneumoniae as the template. The gdrA and gdrB were inserted in pMD-18T to yield the recombinant cloning vector pMD-gdrAB. After th
Publikováno v:
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 16(5)
To study the changes of minimal residual disease (MRD) in children with B cell acute lymphoblastic leukemia (B-ALL) of different genetic abnormalities.Between February 2004 and April 2013, 271 newly diagnosed B-ALL pediatric patients who had finished
Autor:
Pan, Suo, Le-Ping, Zhang, Jun, Wu, Ai-Dong, Lu, Bin, Wang, Ying-Xi, Zuo, Yi-Fei, Cheng, Gui-Lan, Liu
Publikováno v:
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. 15(6)
To explore the efficacy and adverse effects of clofarabine for relapsed/refractory acute lymphoblastic leukemia in children.Twenty-six pediatric patients with relapsed/refractory acute lymphoblastic leukemia were treated with clofarabine. There were